Inhibitory effects of Tomivosertib in acute myeloid leukemia is a research paper published in Oncotarget (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA121192
NCI NIH HHS
Grant: P30 CA060553
NCI NIH HHS
Grant: R01 CA077816
NIH HHS
Grant: S10 OD025194
CSRD VA
Grant: I01 CX000916
NIGMS NIH HHS
Grant: P41 GM108569
National Institutes of Health
Grant: 3P41GM108569-08S1
Expanding Proteoform and Antibody Integration in HuBMAP
National Institutes of Health
Grant: 5P30CA060553-12
The Robert H.Lurie Comprehensive Cancer Center
National Institutes of Health
Grant: 1S10OD025194-01
Acquisition of a Thermo Fisher Scientific Q Exactive UHMR mass spectrometer
National Institutes of Health
Grant: 5R01CA077816-12
Signal Transduction of Type I Interferons in Malignant Cells
National Institutes of Health
Grant: 5I01CX000916-02
Signaling Pathways and Therapeutic Targeting of Leukemic Cells
National Institutes of Health
Grant: 2R01CA121192-06
Arsenic Trioxide activated pathways in malignant cells
Fields of Study
Keywords
Sustainable Development Goals